Agenda

Articles

• Meet Vect-Horus at BIO-Europe Spring® 2015
  28 January 2019, by Jonathan NOWAK

  Meet VECT-HORUSat BIO-Europe Spring® 2015, Paris, France
  March 9-11, 2015

• Meet Vect-Horus at BIO Europe Digital
  14 October 2021, by Elodie DORMES

  Emmanuelle BETTENDORF will participate in BioEurope from October 25 to 27, 2021 and will be available to meet with you on partnership opportunities.

• Meet Vect-Horus at BIO Europe HAMBURG
  31 October 2019, by Elodie DORMES

  VECT-HORUS will attend BIO Europe from November 11–13, 2019
  If you are interested to meet, please use the B2B Partnering system.

• Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
  21 March 2024, by Emmanuelle BETTENDORF

  Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
  The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)

• Selected for a 5’ Pitch at the 2nd edition of the TOULOUSE ONCO WEEK
  28 January 2019, by Jonathan NOWAK

  Cédric MALICET, PhD Oncology Project Manager, will present VECT-HORUS’ proprietary technology platform, VECTrans®, that facilitates the targeted delivery of imaging or therapeutic agents to tumors using receptor mediated transport.
  http://www.toulouse-onco-week.org/index.php?langue=en&onglet=0&acces=&idUser=&emailUser=

• e-Meet Vect-Horus at the digital BIO Spring Paris
  3 March 2020, by Elodie DORMES

  Vect-Horus will attend to the BIO Spring from 23–24 March 2020.
  If you are interested to meet, please use the B2B Partnering system.

• Nanomedicine for treating cancer and brain diseases symposium in MARSEILLE
  6 March 2019, by Jonathan NOWAK

  In the context of the Euronanomed projects for Action on Nanomedicine under Horizon 2020, a Symposium will be held at the Luminy campus in Marseille on March 8, 2019. Dr. Khrestchatisky will give a talk titled "Molecular vectors for drug delivery into the brain and tumors".
  For more information, please visit the symposium website or download the pdf version of the program.

• Vect-Horus will participate to the HealthTech Innovation Days on November 13-14, 2022
  11 October 2022, by Elodie DORMES

  Elodie DORMES, Business Development Manager, will attend the HealthTech Innovation Days in Paris on November 13-14, 2022.
  2 days dedicated to networking and interaction with Biotech and Pharmaceutical companies.

• BiotechShowcase
  3 January 2022, by Elodie DORMES

  Meet Vect-Horus at the first 2022 partnering event from January 17th to January 19th, during the digital week.

• Vect-Horus will be attending the J.P. Morgan 36th Annual Healthcare Conference
  28 January 2019, by Jonathan NOWAK

  January 8-11, 2018 – San Francisco, CA, USA
  If you would like to arrange a one-on-one meeting with Vect-Horus’ team during the conference, please contact Jamal TEMSAMANI, Director of Drug Development & Corporate at jamal.temsamani@vect-horus.com